Abstract
An estimated 300–500 million new infections and 1.5–2.7 million deaths attributed to malaria occur annually in the developing world1, and every year tens of millions of travelers from countries where malaria is not transmitted visit countries with malaria. Because the parasites that cause malaria have developed resistance to many antimalarial drugs, new methods for prevention are required. Intraperitoneal injection into mice of one dose of 150 ng (approximately 7.5 μg per kg body weight) recombinant mouse interleukin-12 (rmlL-12) 2 days before challenge with Plasmodium yoelii sporozoites protects 100% of mice against malaria2. We report that one subcutaneous injection of 10 μg/kg recombinant human IL-12 (rhIL-12) 2 days before challenge with P. cynomolgi sporozoites protected seven of seven rhesus monkeys. Protection was associated with marked increases in plasma levels of interferon-γ (IFN-γ), and relative increases of lymphoid cell messenger RNA coding for IFIM-γ and several other cytokines. We speculate that rIL-12 protects monkeys through IFN-γ-dependent elimination of P. cynomolgi-infected hepatocytes. This first report of rIL-12-induced protection of primates against an infectious agent supports assessment of rhIL-12 for immunoprophylaxis of human malaria.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Organization. Malaria. WHO Fact Sheet 94, 1–3 (1995).
Sedegah, M., Finkelman, F. & Hoffman, S.L. Interleukin-12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. USA 91, 10700–10702 (1994).
Schmidt, L.H., Fradkin, R., Genther, C.S., Rossan, R.N. & Squires, W. Plasmodium cynomolgi infections in the rhesus monkey. II. Responses of sporozoite-induced infections to antimalarial drugs. Am. J. Trap. Med. Hyg. 31 (Suppl.), 646–665 (1982).
Nadeau, R.R., Ostrowski, C., Ni-Wu, G. & Liberate, D.J. Pharmacokinetics and pharmacodynamics of recombinant human interleukin-12 in male rhesus monkeys. J. Pharmacol. Exp. Ther. 274, 78–83 (1995).
Villinger, F. et al. Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononuclear Cells. Cytokine 5, 469–479 (1993).
Villinger, F., Brar, S.S., Mayne, A., Chikkala, N. & Ansari, A.A. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155, 3946–3954 (1995).
Gately, M.K. & Mulqueen, M.J., Interleukin-12:Potential clinical applications in the treatment and prevention of infectious diseases. Drugs 52 (Suppl. 2), 18–26 (1996).
Mellouk, S., Green, S.J., Nacy, C.A. & Hoffman, S.L. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-argininedependent effector mechanism. J. Immunol. 146, 3971–3976 (1991).
Mellouk, S. et al. Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: Enhancement by exogenous tetrahydrobiopterin. Infect. Immun. 62, 4043–4046 (1994).
Maheshwari, R.K. et al. Recombinant human gamma interferon inhibits simian malaria. Infect. Immun. 53, 628–630 (1986).
Maheshwari, R.K. The role of cytokines in malaria infection. Bull. World Health Organ. 68 (Suppl.), 138–144 (1990).
Stevenson, M.M., Tarn, M.F., Wolf, S.F. & Sher, A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155, 2545–2556 (1995).
Morris, S.C. et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol. 152, 1047–1056 (1994).
Wynn, T.A., Eltoum, I., Oswald, I.P., Cheever, A.W. & Sher, A. Endogenous interleukin 12 (IL-12) regulates granuloma formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against eg pathology. J. Exp. Med. 179, 1551–1561 (1994).
Wynn, T.A., Jankovic, D., Hieny, S., Cheever, A.W. & Sher, A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J. Immunol. 154, 4701–1709 (1995).
D'Andrea, A. et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer Cell stimulatory factor/IL-12 synthesis in accessory Cells. J. Exp. Med. 178, 1041–1048 (1993).
Trinchieri, G. lnterleukin-12: A cytokine produced by antigen-presenting Cells with immunoregulatory functions in the generation of T-helper Cells type 1 and cytotoxic lymphocytes. Blood 84, 4008–4027 (1994).
Ling, P. et al. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154, 116–127 (1995).
Wu, C.Y. et al. In vitro maturation of human neonatal CD4+ T lymphocytes. I. Induction of IL-4-producing Cells after long-term culture in the presence of IL-4 plus either IL-2 or IL-12. J. Immunol. 152, 1141–1153 (1994).
Malhotra, K., Salmon, D., Le Bras, J. & Vilde, J.L. Susceptibility of Plasmodium falciparum to a peroxidase-mediated oxygen-dependent microbicidal system. Infect. Immun. 56, 3305–3309 (1988).
Sarmiento, U.M. et al. Biologic effects of recombinant human interleukin-12 in squirrel monkeys (Sciureus saimiri). Lab. Invest. 71, 862–873 (1994).
Puri, S.K., Maheshwari, R.K., Dutta, G.P., Friedman, R.M. & Dhar, M.M. Human interferon-gamma protects rhesus monkeys against sporozoite-induced Plasmodium cynomolgi malaria infection. J. Interferon. Res. 8, 201–206 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoffman, S., Crutcher, J., Puri, S. et al. Sterile protection of monkeys against malaria after administration of interleukin-12. Nat Med 3, 80–83 (1997). https://doi.org/10.1038/nm0197-80
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0197-80
This article is cited by
-
Azadirachta indica (A. Juss.) and Curcuma longa (L.) modulate immunoglobulin and cytokine levels in Plasmodium berghei-infected mice
Comparative Clinical Pathology (2021)
-
Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine
Malaria Journal (2013)
-
Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case–control study
Malaria Journal (2012)
-
Polymorphic variability in the 3' untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malaria
BMC Genetics (2011)
-
Polymorphisms in genes of interleukin 12 and its receptors and their association with protection against severe malarial anaemia in children in western Kenya
Malaria Journal (2010)